Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycyrrhizin in Prostate Cancer
NCT06378346Phase 2Recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2024
- Primary completion
- Mar 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycyrrhizin in prostate cancer (PCa), sponsored by University of Illinois Chicago. Started Jul 2024; status: recruiting.
02
Drugs
glycyrrhizin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06378346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378346.